Comparative Pharmacology
Head-to-head clinical analysis: BANTHINE versus TOLTERODINE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: BANTHINE versus TOLTERODINE.
BANTHINE vs TOLTERODINE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Anticholinergic; competitively blocks muscarinic acetylcholine receptors, inhibiting parasympathetic impulses.
Competitive antagonist of muscarinic acetylcholine receptors (M1, M2, M3, M4, M5), with selectivity for the M3 receptor subtype involved in detrusor muscle contraction, reducing bladder smooth muscle contractility and increasing bladder capacity.
Adults: 50 mg orally four times daily, before meals and at bedtime.
2 mg PO twice daily; may reduce to 1 mg twice daily if tolerated.
None Documented
None Documented
Terminal elimination half-life is approximately 2.5–3 hours in adults with normal renal function. In elderly or those with renal impairment, half-life may be prolonged to 6–8 hours, requiring dose adjustment.
Clinical Note
moderateTolterodine + Sulfisoxazole
"The metabolism of Sulfisoxazole can be decreased when combined with Tolterodine."
Clinical Note
moderateTolterodine + Cyclosporine
"The metabolism of Cyclosporine can be decreased when combined with Tolterodine."
Clinical Note
moderateTolterodine + Fluconazole
"The metabolism of Fluconazole can be decreased when combined with Tolterodine."
Clinical Note
moderateTolterodine + Clotrimazole
Terminal elimination half-life is 2-4 hours in extensive CYP2D6 metabolizers; increased to 4-10 hours in poor metabolizers or with CYP3A4 inhibitors.
BANTHINE (methantheline) is primarily eliminated via renal excretion (approximately 70% unchanged) with the remainder as metabolites. Biliary/fecal elimination accounts for less than 15%. Total recovery in urine and feces is nearly complete.
Primarily hepatic metabolism via CYP2D6 and CYP3A4; renal excretion accounts for <5% of unchanged drug; ~80% excreted in urine as metabolites, ~20% in feces.
Category C
Category A/B
Anticholinergic
Anticholinergic
"The metabolism of Clotrimazole can be decreased when combined with Tolterodine."